Quick Answer
RIGEL PHARMACEUTICALS INC reported Total Assets of $513.59 million for fiscal year 2025.
RIGEL PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $513.59M | +213.2% |
| 2024 | $163.98M | +39.9% |
| 2023 | $117.22M | -12.7% |
| 2022 | $134.28M | -19.8% |
| 2021 | $167.33M | +51.6% |
| 2020 | $110.38M | -25.2% |
| 2019 | $147.57M | +6.1% |
| 2018 | $139.11M | +16.8% |
| 2017 | $119.11M | +52.4% |
| 2016 | $78.13M | -40.7% |
| 2015 | $131.75M | -14.5% |
| 2014 | $154.13M | -31.8% |
| 2013 | $226.06M | -27.1% |
| 2012 | $310.04M | +20.6% |
| 2011 | $257.11M | +37.7% |
| 2010 | $186.69M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $242.53M | +74.0% | +17.3% |
| June 30, 2025 | $206.74M | +61.0% | +17.5% |
| March 31, 2025 | $175.97M | +39.1% | +7.3% |
| December 31, 2024 | $163.98M | +39.9% | +17.6% |
| September 30, 2024 | $139.42M | +20.9% | +8.6% |
| June 30, 2024 | $128.41M | +9.7% | +1.5% |
| March 31, 2024 | $126.52M | +2.4% | +7.9% |
| December 31, 2023 | $117.22M | -12.7% | +1.6% |
- RIGEL PHARMACEUTICALS INC showed an increase of +213.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, RIGEL PHARMACEUTICALS INC’s total assets has grown by 175.1% (from $186.69 million to $513.59 million).
- The most recent figure is from RIGEL PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: